Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk -- Ignore unavailable to you. Want to Upgrade?

To: isopatch who wrote (174539)	6/7/2022 3:15:38 PM
From: Winfastorlose	11 Recommendations Recommended By Ben Smith briskit easygoer h_ Hugh Bett and 6 more members Read Replies (2) \| Respond to of 207847

I have been following virology since the late 80s and I learned a several new things from that interview. For example, that antibodies never see a virus in the lungs in a respiratory infection. I knew that for the most part, your defense against viruses primarily comes from your t-cells, but I had never read anything about antibodies being almost totally useless against viruses in the lungs. How anyone can ignore Michael Yeadon is beyond me. The fact he was Chief of Science for Pfizer for so many years and that he specialized in respiratory should have given him instant credibility during this controversy. He obviously knows much more about this topic than the doofuses that have been held up as experts by the powers that be. And as he said, there is no upside whatsoever in him doing what he is doing. It has only cost him to do it.